MARKET

CTSO

CTSO

Cytosorbents Corp
NASDAQ
0.4811
+0.0141
+3.02%
Opening 14:31 06/25 EDT
OPEN
0.4800
PREV CLOSE
0.4670
HIGH
0.4900
LOW
0.4551
VOLUME
34.16K
TURNOVER
--
52 WEEK HIGH
1.390
52 WEEK LOW
0.3695
MARKET CAP
30.21M
P/E (TTM)
-2.5215
1D
5D
1M
3M
1Y
5Y
1D
CytoSorbents Advances FDA Pathway for DrugSorb Programs
TipRanks · 11h ago
CytoSorbents posts investor presentation outlining blood purification products, DrugSorb-ATR regulatory path
PUBT · 12h ago
Weekly Report: what happened at CTSO last week (0615-0619)?
Weekly Report · 3d ago
CytoSorbents CEO to present at Virtual Investor Conferences Life Sciences Forum
PUBT · 06/18 12:46
CytoSorbents CFO Peter J. Mariani acquires 100,000 common shares worth $44,000
PUBT · 06/16 11:01
CytoSorbents CEO Phillip P. Chan acquires common shares worth $104,109.32
PUBT · 06/15 22:25
Weekly Report: what happened at CTSO last week (0608-0612)?
Weekly Report · 06/15 10:20
CytoSorbents announces annual shareholder meeting
PUBT · 06/11 21:05
More
About CTSO
CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery through blood purification. The Company’s blood purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its lead product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses that can lead to massive inflammation, organ failure and patient death. Its products also include ECOS-300CY, VetResQ, DrugSorb-ATR, and PuriFi. DrugSorb-ATR is an investigational device that uses equivalent polymer technology to CytoSorb to address a large unmet need for blood thinner reversal in cardiothoracic surgery. ECOS-300CY is used to reduce cytokines and other inflammatory mediators when used in an ex vivo organ perfusion system.

Webull offers Cytosorbents Corp stock information, including NASDAQ: CTSO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTSO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTSO stock methods without spending real money on the virtual paper trading platform.